{"id":"W4401877474","doi":"10.1016/s2152-2650(24)00811-5","title":"Glofitamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma: Extended Follow-Up from a Pivotal Phase 2 Study and Subgroup Analyses in Patients with Prior Chimeric Antigen Receptor T-Cell Therapy and by Baseline Total Metabolic Tumor Volume","year":2024,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Chimeric antigen receptor; Oncology; Refractory (planetary science); Internal medicine; Lymphoma; Phases of clinical research; Immunotherapy; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003545213,0.001734447,0.003826748,0.0005566059,0.0004466489,0.001721887,0.0008538154,0.001060412,0.001859165],"category_scores_gemma":[0.001649569,0.0005903561,0.004608502,0.0008119321,0.0006593918,0.001555244,0.0006098279,0.002046325,0.0003846293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008493399,"about_ca_system_score_gemma":0.000859898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009137427,"about_ca_topic_score_gemma":0.002781959,"domain_scores_codex":[0.9987348,0.0005448706,0.00007803787,0.0002635949,0.0001092307,0.0002696316],"domain_scores_gemma":[0.9988081,0.0003356496,0.0002995017,0.0002081923,0.0000700414,0.0002785299],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8259679,0.002519117,0.08023375,0.0006898216,0.02444057,0.0003493977,0.0002188568,0.00252699,0.013023,0.0001579072,0.002189344,0.04768328],"study_design_scores_gemma":[0.2887262,0.09800944,0.5632176,0.0001531093,0.03573618,0.0008461651,0.0004816795,0.003460342,0.003233621,0.0008503831,0.005052189,0.0002330459],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933351,0.004496175,0.0002666658,0.0001664892,0.00006060576,0.0001649712,0.001017476,0.0000305182,0.000461991],"genre_scores_gemma":[0.9953132,0.001013316,0.0002232973,0.0002581251,0.00009554394,0.0001640235,0.002467651,0.00001671789,0.0004481985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003826748,"threshold_uncertainty_score":0.01874906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03002029728337518,"score_gpt":0.3461436852849306,"score_spread":0.3161233880015554,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}